|
|
See Category: Neoplasms
ICD-10 (CM) Code and Descriptor
|
D33.2 |
Benign neoplasm of brain, unspecified
|
D332 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 38.59%
|
18.63%
|
11.76%
|
8.27%
|
5.99%
|
3.97%
|
3.32%
|
3.21%
|
1.46%
|
0.84%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for D33.2*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
97530
|
THERAPEUTIC ACTIVITIES |
693
|
1,211
|
|
70553
|
MRI BRAIN STEM W/O & W/DYE |
587
|
590
|
|
97110
|
THERAPEUTIC EXERCISES |
558
|
852
|
|
97112
|
NEUROMUSCULAR REEDUCATION |
282
|
402
|
|
97116
|
GAIT TRAINING THERAPY |
266
|
338
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
261
|
261
|
|
97535
|
SELF CARE MNGMENT TRAINING |
229
|
400
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
209
|
209
|
|
A9585
|
GADOBUTROL INJECTION |
176
|
13,334
|
|
A9575
|
INJ GADOTERATE MEGLUMI 0.1ML |
173
|
23,016
|
|
82565
|
ASSAY OF CREATININE |
160
|
160
|
|
G1004
|
CDSM NDSC |
154
|
159
|
|
92526
|
ORAL FUNCTION THERAPY |
143
|
143
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
134
|
134
|
|
80053
|
COMPREHEN METABOLIC PANEL |
115
|
115
|
|
A9577
|
INJ MULTIHANCE |
104
|
1,553
|
|
70450
|
CT HEAD/BRAIN W/O DYE |
75
|
75
|
|
92507
|
TX SP LANG VOICE COMM INDIV |
75
|
75
|
|
97542
|
WHEELCHAIR MNGMENT TRAINING |
70
|
95
|
|
A9579
|
GAD-BASE MR CONTRAST NOS,1ML |
63
|
977
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
D33.2 related to the following DRG Codes:
054-055
|
